A visco injection, short for viscosupplementation, is an injection of hyaluronic acid into a joint to restore lubrication and cushioning lost to osteoarthritis. The procedure is FDA-approved specifically for knee osteoarthritis and is typically recommended after basic treatments like pain relievers and physical therapy haven’t provided enough relief. Think of it as replenishing the natural shock-absorbing fluid your joint no longer produces well on its own.
How Visco Injections Work
Healthy joints contain synovial fluid, a thick substance that acts as both a lubricant and a shock absorber. The key ingredient in this fluid is hyaluronic acid, a naturally occurring molecule produced by cells in the joint lining. In osteoarthritis, hyaluronic acid breaks down and thins out, which means the joint loses its ability to cushion impacts and reduce friction between bones.
A visco injection delivers a synthetic or purified version of hyaluronic acid directly into the joint space. Once there, it does more than just lubricate. It also reduces inflammation, helps distribute weight-bearing forces more evenly across the joint surface, and may have a protective effect on the remaining cartilage. These combined mechanical and biochemical effects are what distinguish it from a simple lubricant replacement.
Who Qualifies for the Injection
Visco injections aren’t a first-line treatment. Medicare and most insurance plans require documented evidence that you’ve tried and failed to get adequate relief from simpler approaches over at least three months. That typically means you’ve already tried over-the-counter pain relievers, exercise or physical therapy, weight loss if relevant, and assistive devices like a brace or cane. Your medical record needs to reflect this history before coverage kicks in.
The injections are FDA-approved only for osteoarthritis of the knee. Some providers use them off-label in hips, shoulders, and ankles, but those uses haven’t been formally tested or approved.
Available Products and Injection Schedules
There are over a dozen FDA-approved viscosupplementation products, and they differ mainly in how many injections you need per treatment course. The original formulations require three to five weekly office visits. Brands like Euflexxa, Orthovisc, and Synvisc use a three-injection series, while Hyalgan and Genvisc 850 may require up to five weekly injections.
Single-injection options became available starting with Synvisc-One in 2009. Other one-shot products include Durolane, Gel-One, and Monovisc. These are more convenient but can cost more per treatment. For example, a three-injection series of Supartz FX runs about $400 total for the drug and procedure costs, while a single Monovisc injection costs around $827. Your insurance plan and copay structure will largely determine which product makes financial sense.
What the Procedure Feels Like
The injection itself is straightforward and takes only a few minutes in an office setting. Your provider cleans the skin around your knee, may numb the area with a local anesthetic, and inserts a needle into the joint space. If there’s excess fluid in the knee, they’ll often drain it before injecting the hyaluronic acid. Some providers use ultrasound to guide the needle, though research shows that experienced clinicians achieve comparable results with or without imaging guidance for routine knee injections.
Afterward, plan to take it easy for one to two days. The first 24 hours should involve relative rest of the injected knee to allow proper absorption and to watch for any reaction. After 24 to 48 hours, you can begin progressive activity: stationary biking, an elliptical, or light bodyweight exercises. Full activity resumes as your symptoms allow.
How Well They Work and How Long Relief Lasts
Pain relief from visco injections builds gradually. Most people start noticing improvement around four weeks after the first injection, with peak benefit at roughly eight weeks. This timeline contrasts with corticosteroid injections, which work faster but wear off sooner. At the four-week mark, the two are roughly equal. From five to thirteen weeks, hyaluronic acid outperforms corticosteroids.
The effects aren’t permanent, but they are meaningful. A Cochrane review found beneficial effects on pain, function, and overall patient assessment during the 5 to 13 week window. At six months, there’s still a measurable benefit compared to placebo, though it’s fading. Patient satisfaction scores reflect this arc: a median of 8 out of 10 at three and six weeks, dropping to 7 out of 10 at twelve weeks, and holding there through six months. Most people repeat the treatment every six months to a year to maintain results.
Can Visco Injections Delay Knee Replacement?
One of the most compelling reasons to consider visco injections is their potential to push back the timeline for knee replacement surgery. A large study using U.S. health claims data from over 182,000 knee osteoarthritis patients found a clear, dose-dependent relationship. Patients who never received hyaluronic acid injections had a median time from diagnosis to knee replacement of just 114 days. Those who did receive injections had a median of 484 days.
The more treatment courses a patient completed, the longer the delay. One course of injections doubled the average time to surgery from 0.7 years to 1.4 years. Patients who completed five or more courses delayed surgery by an average of 3.6 years. For someone who isn’t ready for surgery or wants to postpone it, that’s a significant window.
Side Effects and Risks
Visco injections are generally well tolerated. The most common side effect is a local reaction at the injection site: temporary swelling and pain in the knee within 72 hours of the shot. This sometimes gets called a “pseudo-septic reaction” because it mimics a joint infection, but it resolves on its own and isn’t actually an infection.
In first-time treatment courses, about 2% of patients experienced a reaction severe enough to seek unscheduled medical care. With repeated series, that rate per injection stays low, around 1.3%, though a slightly higher percentage of knees (up to 3.6%) will have a notable reaction at some point during a second round. The risk doesn’t appear to escalate dramatically with additional courses. Serious complications like true joint infection are rare, as with any injection into a joint.
What to Expect Overall
Visco injections occupy a middle ground in osteoarthritis management. They’re not as quick as a cortisone shot and not as definitive as a knee replacement. Their strength is in providing moderate, sustained pain relief with minimal side effects, buying time for people whose arthritis is too advanced for basic measures but who aren’t ready for surgery. If your provider has mentioned visco injections, you’re likely in that in-between stage where the goal is to maintain function and manage pain for as long as possible before considering more invasive options.